Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.
Orfali N, Zhang MJ, Allbee-Johnson M, Boelens JJ, Artz AS, Brunstein CG, McNiece IK, Milano F, Abid MB, Chee L, Diaz MA, Grunwald MR, Hematti P, Hsu J, Lazarus HM, Munshi PN, Prestidge T, Ringden O, Rizzieri D, Riches ML, Seo S, Solh M, Solomon S, Szwajcer D, Yared J, van Besien K, Eapen M.
Orfali N, et al. Among authors: lazarus hm.
Transplant Cell Ther. 2021 Dec;27(12):993.e1-993.e8. doi: 10.1016/j.jtct.2021.08.031. Epub 2021 Oct 2.
Transplant Cell Ther. 2021.
PMID: 34507002
Free PMC article.